Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer (Oncotarget (2016) 7 (3884-3896) DOI: 10.18632/oncotarget.6461)

Naiqing Xu, Wenfeng Fang, Libing Mu, Yanna Tang, Lei Gao, Shengxiang Ren, Dengfeng Cao, Lixin Zhou, Aiqun Zhang, Deruo Liu, Caicun Zhou, Kwok Kin Wong, Lei Yu, Li Zhang, Liang Chen

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been corrected: The correct Grant Support information is given below: GRANT SUPPORT This work was funded by National Natural Science Foundation of China grant 81472606, Chinese Ministry of Science and Technology grant (973 grant) 2011CB812401, and the Beijing Municipal Government.

Original languageEnglish (US)
Pages (from-to)35284
Number of pages1
JournalOncotarget
Volume9
Issue number81
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer (Oncotarget (2016) 7 (3884-3896) DOI: 10.18632/oncotarget.6461)'. Together they form a unique fingerprint.

Cite this